← All stocks

MYOMO, INC.

MYO Net buying
CIK 0001369290 #4562 in the set updated 17 Sep 2026
Bought (120 mo)
$1.97M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$796.57K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$796.57K
21 of 22 sales
Net
+$1.17M
+$1.17M against sales at will

By person

17 insiders · 73 transactions
4.8×

Paul R. Gudonis holds only 4.8 times base salary in stock. $1.82M of shares against $375.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul R. Gudonis last reported holding, valued at $1.27, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
KIRK THOMAS F
Director
$1.17M (18)
+$1.17M
772,569
$981.86K
GUDONIS PAUL R
Chief Executive Officer
$436.57K (11)
+$436.57K
1,434,679
$1.82M
Kovelman Harry
Chief Medical Officer
$5.00K (1)
$411.00K (9)
−$406.00K
90,245
$114.69K
+1,171%
Mitchell Micah
Chief Commercial Officer
$5.00K (1)
$325.25K (4)
−$320.25K
130,738
$166.15K
Manko Joseph M. Jr.
Director
$173.91K (2)
+$173.91K
2,388,479
$3.04M
+13.3%
HENRY DAVID A
Chief Financial Officer
$88.28K (5)
+$88.28K
470,163
$597.53K
Getz Heather C
Director
$64.93K (2)
+$64.93K
210,458
$267.47K
Crowley Thomas Aloysius Jr.
Director
$3.23K (2)
$39.17K (8)
−$35.94K
154,931
$196.90K
Morris Milton Mayo
Director
$15.87K (1)
$21.15K (1)
−$5.28K
208,391
$264.84K
Naft Jonathan
VP, General Manager
(1)
$0.00
22,298
$28.34K
Sanghi Steve
Director
(1)
$0.00
570,621
$725.20K
FEBBO WILLIAM J
Director
123,704
$157.22K
Knapp Amy K.
Director
91,645
$116.47K
GOLDWASSER RALPH A
Chief Financial Officer
78,619
$99.92K
+690.5%
Mendelsohn Davie
VP, Sales
36,099
$45.88K
+98.7%
CONNEIGHTON CLIFF
Chief Marketing Officer
17,738
$22.54K
Green Brandon M
Chief Medical Officer
1,664
$2.11K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Kovelman Harry
11 Sep 2026
Chief Medical Officer
Sell
15,488
$1.27
$19.68K
Morris Milton Mayo
2 Sep 2026
Director
Sell
15,000
$1.41
$21.15K
Kovelman Harry
20 Aug 2026
Chief Medical Officer
Sell
17,250
$1.73
$29.90K
Kovelman Harry
28 May 2026
Chief Medical Officer
Sell
11,536
$1.02
$11.73K
Kovelman Harry
27 May 2026
Chief Medical Officer
Sell
20,464
$1.00
$20.50K
Mitchell Micah
14 May 2025
Chief Commercial Officer
Sell
90,231
$0.86
$77.69K
Mitchell Micah
14 Mar 2025
Chief Commercial Officer
Sell
48,000
$5.16
$247.56K
Kovelman Harry
12 Mar 2025
Chief Medical Officer
Sell
30,000
$5.50
$165.02K
Kovelman Harry
5 Sep 2024
Chief Medical Officer
Sell
6,700
$3.76
$25.18K
Kovelman Harry
3 Sep 2024
Chief Medical Officer
Sell
2,029
$4.01
$8.14K
Kovelman Harry
15 May 2024
Chief Medical Officer
Sell
35,426
$3.69
$130.84K
Crowley Thomas Aloysius Jr.
8 Dec 2023
Director
Sell
14,997
no price
Crowley Thomas Aloysius Jr.
28 Nov 2023
Director
Sell
14,997
no price
Crowley Thomas Aloysius Jr.
5 Aug 2022
Director
Sell
7,141
$1.71
$12.22K
Crowley Thomas Aloysius Jr.
14 Jun 2022
Director
Sell
291
$1.67
$485.39
Crowley Thomas Aloysius Jr.
10 Jun 2022
Director
Sell
6,000
$1.97
$11.79K
Crowley Thomas Aloysius Jr.
9 Jun 2022
Director
Sell
110
$2.15
$236.06
Crowley Thomas Aloysius Jr.
8 Jun 2022
Director
Sell
3,000
$2.15
$6.44K
Crowley Thomas Aloysius Jr.
6 Jun 2022
Director
Sell
3,500
$2.29
$8.00K
Mitchell Micah
21 Jul 2021
Chief Commerical Officer
Sell
1,385
no price
Mitchell Micah
20 Jul 2021
Chief Commerical Officer
Sell
5,745
no price

What was left out

Form 4 filings counted 245
Amendments (4/A) skipped 17
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 21
Transactions with no price 9
Shares from compensation/vesting 4,878,135
Sales filed before the plan box existed 3
History held since 13 Jun 2017